WallStreetZenWallStreetZen

NASDAQ: SCTX
Scribe Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Scribe Therapeutics earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest SCTX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$17.3M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SCTX reported annual earnings of -$21.8M, with -54.4% growth.

SCTX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

SCTX Return on Equity

Insufficient data to display

SCTX Return on Assets

Insufficient data to display

Be the first to know when SCTX announces earnings.

SCTX Return on Capital Employed

Current Company
0%
Current Industry
-9.6%

SCTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.47M-$69.87MN/A-$3.21
ACET-$99.45M-$108.83MN/A-$13.87
ABVX-$249.95M-$390.82MN/A-$5.28
ACXP-$7.50M-$7.50MN/A-$4.05
ABVC-$7.88M-$8.63MN/A-$0.39
View Top Biotech Stocks

Scribe Therapeutics Earnings Reports & History FAQ

What were Scribe Therapeutics's earnings last quarter?

Scribe Therapeutics (NASDAQ: SCTX) reported Q1 2026 earnings per share (EPS) of -$7.05, up 396.48% year over year. Total SCTX earnings for the quarter were -$17.35 million. In the same quarter last year, Scribe Therapeutics's earnings per share (EPS) was -$1.42.

If you're new to stock investing, here's how to buy Scribe Therapeutics stock.

Is Scribe Therapeutics profitable or losing money?

As of the last Scribe Therapeutics earnings report, Scribe Therapeutics is currently losing money. Scribe Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was SCTX's earnings growth in the past year?

As of Scribe Therapeutics's earnings date in Q3 2026, Scribe Therapeutics's earnings has grown year over year. SCTX earnings in the past year totalled N/A.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.